It is a link for moving within the page.

Go to the main.
Go to the global navigation.
Go to navigation by category.
Go to the footer.

News Releases

2021

April

15 APR 2021Corporate: Otsuka Pharmaceutical Receives First Certification as Tokyo Metropolitan Government Sports Promotion Model Company (Practical Division) Recognized for providing opportunities for exercise adapted for new lifestyles

13 APR 2021Pharmaceuticals: Otsuka and Lundbeck announce decision to continue phase III clinical trial evaluating brexpiprazole for treatment of agitation in patients with Alzheimer's-type dementia

March

30 MAR 2021Pharmaceuticals: Otsuka and Akebia Announce Submission of New Drug Application to the FDA for Approval of Akebia's Vadadustat

24 MAR 2021Pharmaceuticals: Otsuka to Launch QuickNavi^TM-H.pylori, a Helicobacter pylori Quick Detection Kit- Test results in eight minutes and stool collection tools provided in one pack -

22 MAR 2021Pharmaceuticals: Otsuka Has Filed an Application in Japan for Regulatory Approval of OPC-61815, a V₂ -Receptor Antagonist for the Treatment of Cardiac Edema

22 MAR 2021Pharmaceuticals: New Drug Application for Oral Disintegrated Tablet Formulation of TAKECAB_® for Treatment of Acid-Related Disease

16 MAR 2021Pharmaceuticals: Otsuka and Perception Neuroscience Announce Collaboration on Development of PCN-101 (R-ketamine) in Japan for Treatment of Depressive Disorders

10 MAR 2021Corporate: Otsuka Pharmaceutical Appointments of Board Members and Statutory Auditors (PDF:57.4 KB)

2 MAR 2021Nutraceuticals: A Delicious Snack That's Good for You Announcing SOYJOY Coffee & Nuts Soy protein from low-GI whole soy

February

26 FEB 2021Nutraceuticals: Convenient Sizes of UL·OS Medicated Scalp Shampoo and Medicated Skin Wash Launched to Promote Trial Use

25 FEB 2021Corporate: Otsuka to Construct a Drug Discovery Center in Osaka Prefecture, Japan

9 FEB 2021Corporate: Office Divisions of Five Otsuka Group Companies to Switch to Green Power

3 FEB 2021Pharmaceuticals: Otsuka and Illumina Announce Agreement on Development and Commercialization of IVD Test Kit for Patients in Japan with Blood Cancer

1 FEB 2021Corporate: Otsuka Pharmaceutical Certified as Sports Yell Company for 4th Consecutive Year -Providing Opportunities for Exercise Tailored for New Lifestyles-

January

29 JAN 2021Corporate: Otsuka Pharmaceutical to Transfer All Shares of Bean Stalk Snow to Megmilk Snow Brand

18 JAN 2021Nutraceuticals: Introduction of POCARI SWEAT Label-free Bottles
Revamped packaging to contribute to a sustainable society

2020

December

17 DEC 2020Pharmaceuticals: Formation of a Licensing Agreement Covering Japan and Europe for the Lupus Nephritis Drug "Voclosporin"

10 DEC 2020Nutraceuticals: Otsuka Pharmaceutical Signs On as "B. League Supporting Company"
-To cooperate with physical conditioning and regional healthcare-related initiatives-

November

16 NOV 2020Nutraceuticals: UL·OS Medicated Scalp Shampoo and Medicated Skin Wash to Appear in New Packaging

October

30 OCT 2020Pharmaceuticals: Quick Navi^TM Rapid Diagnostic Test in Japan Now Supports Simultaneous Testing for Influenza and COVID-19 Through Collection of a Single Testing Sample

15 OCT 2020Nutraceuticals: Debut of InnerSignal Skin Care Brand Outside Japan - Launched in South Korea as Functional Cosmetics with Two Key Benefits -

15 OCT 2020Pharmaceuticals: Otsuka and its subsidiary Astex announce results of phase 3, ASTRAL-2 and ASTRAL-3 trials of guadecitabine in patients with previously treated AML and MDS/CMML

12 OCT 2020Pharmaceuticals: Positive Top-Line Results in Phase 3 Trial of OPC-61815, a V₂ -Receptor Antagonist for the Treatment of Cardiac Edema

5 OCT 2020Pharmaceuticals: Quick Navi^TM-COVID 19 Ag Rapid Diagnostic Test in Japan Now Enables Test Sample Collection from Front of Nasal Cavity

September

30 SEP 2020Corporate: Otsuka Group Acquires ISO 14001 Certification -Reinforcement of group-wide environmental initiatives-

28 SEP 2020Pharmaceuticals: Otsuka Has Filed an Application in Japan for Approval of Difamilast (OPA-15406) as an Atopic Dermatitis Drug

25 SEP 2020Pharmaceuticals: Otsuka's ABILIFY MAINTENA approved for the additional indication of bipolar I disorder in Japan

18 SEP 2020Nutraceuticals: - Creating a Society that Supports Ongoing Employee Health - Full-scale launch of "Kenko Shacho" community website connecting corporate leaders

10 SEP 2020Nutraceuticals: Smart Nutrition for New Lifestyles Announcing SOYJOY Green Tea & Macadamia Moist Texture Highlights the Mellow Astringency and Savor of Green Tea

7 SEP 2020Nutraceuticals: Otsuka Pharmaceutical Supports High School Students in Summer 2020
Supporting events across Japan that are close to their hearts, including alternative athletic competitions

3 SEP 2020Pharmaceuticals: Top-line Results from Global Phase 3 Program of Vadadustat, a Drug Candidate for Treatment of Renal Anemia due to Chronic Kidney Disease in Non-Dialysis Patients

August

26 AUG 2020Pharmaceuticals: Novartis Pharma and Otsuka to Launch Entresto^® Tablets in Japan for Patients with Chronic Heart Failure

11 AUG 2020Pharmaceuticals: Otsuka to Co-market New Diagnostic Test for COVID-19, Quick Navi-COVID 19 Ag-Confirmation of test results in just 15 minutes, and easy-to-read results shown in two contrasting colors-

July

29 JUL 2020Pharmaceuticals: Otsuka Filed Application in Japan for Approval of Fremanezumab as a Prophylactic Treatment for Migraine

8 JUL 2020Pharmaceuticals: Otsuka announces simultaneous regulatory approvals by U.S. FDA and Health Canada of INQOVI^®, an oral hypomethylating agent (HMA) therapy for MDS and CMML

June

29 JUN 2020Pharmaceuticals: Novartis Pharma obtains manufacturing and marketing approval in Japan for Entresto^® tablet as angiotensin receptor neprilysin inhibitor (ARNI) for chronic heart failure

29 JUN 2020Pharmaceuticals: Samsca^®approved in Japan for additional indication of hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion (SIADH)

29 JUN 2020Pharmaceuticals: Otsuka Pharmaceutical and Axcelead Drug Discovery Partners announce joint research in CNS indications

24 JUN 2020Pharmaceuticals: Clinical program for NY-ESO-1/siTCR^TM gene therapy candidate receives designation in Japan as Orphan Regenerative Medicine

19 JUN 2020Pharmaceuticals: Japan's MHLW grants Sakigake Designation to comprehensive genomic profiling assay for hematologic malignancies co-developed by Otsuka

16 JUN 2020Nutraceuticals: Introduction of Set of Heat Disorder-related Teaching Materials: "Get Back That Sweat! Preventing Heat Disorders Together"

16 JUN 2020Pharmaceuticals: Launch of a New Combination Ophthalmic Solution for the Treatment of Glaucoma and Ocular Hypertension, AILAMIDE^® Combination Ophthalmic Suspension

12 JUN 2020Pharmaceuticals: Otsuka Announces Positive Top-line Results from Two Phase 3 Studies of Centanafadine for the Treatment of Attention-deficit Hyperactivity Disorder (ADHD) in Adult Patients

May

25 MAY 2020Pharmaceuticals: Deltyba^® (delamanid) approved in Russian Federation for treatment of pulmonary multidrug-resistant tuberculosis (MDR-TB)

22 MAY 2020Pharmaceuticals: Launch of Aspirin/Vonoprazan Fumarate Combination Tablets: "Cabpirin_® Combination Tablets"

5 MAY 2020Pharmaceuticals: Positive Top-Line Results from Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis

April

27 APR 2020Corporate: Otsuka Pharmaceutical to use CO2-free electricity at all plants in Japan (PDF:96.4 KB)

24 APR 2020Nutraceuticals: Research on the Relationship Between Hair Problems and Capacity to Produce Equol

20 APR 2020Pharmaceuticals: Otsuka Enters into Licensing Agreement in Japan for Bempedoic Acid, a Treatment for Hypercholesterolemia

1 APR 2020Pharmaceuticals: Otsuka to Introduce QuickNavi^TM-Adeno2, an Adenovirus Quick Measurement Kit- Faster and clearer test results with two contrasting colors -

March

26 MAR 2020Pharmaceuticals: Development of the first comprehensive genomic profiling assay for hematologic malignancies in Japan- Consortium of major Japanese hospitals and Otsuka Pharmaceutical start a project to evaluate its clinical utility -

26 MAR 2020Pharmaceuticals: Otsuka Announces Top-line Results from Two Phase 3 Studies in Japan for Atopic Dermatitis Drug Candidate Difamilast (OPA-15406)

25 MAR 2020Pharmaceuticals: Otsuka's Busulfex Receives Additional Indication in Japan as a Conditioning regimen Prior to Autologous Hematopoietic Stem Cell Transplantation for Malignant Lymphoma

25 MAR 2020Pharmaceuticals: Cabpirin_® Combination Tablet Receives Regulatory Approval in Japan for Treatment of Acid-related Diseases in Patients Needing Low-dose Aspirin

16 MAR 2020Nutraceuticals: Dietary Education App "SketchCook"
Recognized with Ministry of Education, Culture, Sports, Science and Technology（MEXT）
"Award for Companies Promoting Experience-based Learning Activities for Youth 2019"

13 MAR 2020Nutraceuticals: Newly published findings on inhibitory effect of near-infrared (IRA) radiation on human epidermal cell proliferation and potential mechanisms

10 MAR 2020Corporate: Otsuka Pharmaceutical Reappointments and New Appointments of Board Members and Statutory Auditors (PDF:57.4 KB)

3 MAR 2020Nutraceuticals: Introducing InnerSignal Rejuvenate ONE－All-in-One Skin Care Product with Time-Lapse Penetration Combines Lightening and Three Basic Skin Care Functions－

2 MAR 2020Pharmaceuticals: Otsuka enters into co-promotion agreement for angiotensin receptor neprilysin inhibitor (ARNI) LCZ696 in Japan

February

27 FEB 2020Pharmaceuticals: First-of-its-kind global collaboration launched to develop transformative treatment regimens for tuberculosis

27 FEB 2020Pharmaceuticals: Otsuka Pharmaceutical Establishes Subsidiary in Malaysia

27 FEB 2020Nutraceuticals: Introducing New UL·OS Face & Body Sheet A single sheet provides convenient facial and body care

26 FEB 2020Nutraceuticals: Launch of "Health Support Plus"
Service to manage workforce health based on desknet's NEO groupware

25 FEB 2020Nutraceuticals: Whole soy nutrition bar delivers the same satisfying crunchy texture with a significant reduction in sugars
SOYJOY Peanuts Renewal Launch

14 FEB 2020Pharmaceuticals: Otsuka Pharmaceutical and the Japan Kidney Association Form Collaborative Agreement -Aim to identify practical uses of basic research in the kidney field-

12 FEB 2020Pharmaceuticals: Otsuka announces that subsidiary Astex Pharmaceuticals' NDA for ASTX727 (oral C-DEC), for the treatment of MDS and CMML, has been accepted for priority review by the U.S. FDA

6 FEB 2020Nutraceuticals: Tokyo Marathon 2020 - Connecting With the World Otsuka Pharmaceutical to be an Official Partner for 14th consecutive year

January

31 JAN 2020Nutraceuticals: Otsuka Pharmaceutical Establishes Health Beverage Subsidiary in Mexico

27 JAN 2020Pharmaceuticals: Otsuka announces positive top-line results from clinical trials in Japan offremanezumab as a prophylactic treatment for migraine

24 JAN 2020Corporate: Otsuka Pharmaceutical Awarded Grand Prize in Tokyo Metropolitan Government Women's Participation Awards for First Year of the Reiwa Era

21 JAN 2020Pharmaceuticals: Otsuka enters multi-project drug discovery collaboration with PhoreMost Limited

2019

December

11 DEC 2019Corporate: Announcement of Changes in Company Officers at Otsuka Pharmaceutical Co., Ltd. (PDF:65.0 KB)

9 DEC 2019Pharmaceuticals: Senju and Otsuka Launch a New Treatment for Glaucoma and Ocular Hypertension - AIBETA^® Combination Ophthalmic Solution

November

28 NOV 2019Pharmaceuticals: POConePlus_® Infrared Spectrophotometer for Diagnosis of H. pylori infection launched in Japan

27 NOV 2019Corporate: Construction Completed on Otsuka's New Pharmaceutical Factory Plant in Mima City, Tokushima Prefecture, Japan

27 NOV 2019Pharmaceuticals: Otsuka Launches New SAMSCA Formulation in Japan: SAMSCA^® OD Tablets

18 NOV 2019Corporate: Otsuka Pharmaceutical Cosponsors "Asan Walking Festa in Itano" as Part of Community Health Promotion Efforts

12 NOV 2019Pharmaceuticals: Otsuka Pharmaceutical and Avanir Pharmaceuticals to Continue Clinical Development ofInvestigational AVP-786 for the Treatment of Agitation in Patients with Alzheimer's Dementia

October

16 OCT 2019Pharmaceuticals: RS Virus Rapid-measurement Kit Quick Navi^TM-RSV2 To Be Launched in Japan- Faster test results and enhanced visual features with two color lines -

15 OCT 2019Nutraceuticals: Presentation of Effects of lactic acid bacterium B240 at Palynological Society of Japan

1 OCT 2019Nutraceuticals: Three New Flavors of Easy-to-Drink Balanced Nutrition Beverage
Introducing Calorie Mate Liquid

September

27 SEP 2019Pharmaceuticals: Otsuka's Subsidiary Avanir Pharmaceuticals Reports Top-line Data from Second Phase 3 Trial Evaluating Investigational AVP-786 for the Treatment of Moderate-to-Severe Agitation in Patients with Alzheimer's Dementia

26 SEP 2019Pharmaceuticals: Otsuka Applies for the Additional Indication in Japan of Bipolar Disorder for ABILIFY MAINTENA for Suspended Release Injectable Suspension

26 SEP 2019Nutraceuticals: New Series Expands the SOYJOY Line of Whole Soy Nutrition Bars SOYJOY Scone Bar Plain

20 SEP 2019Corporate: Otsuka Pharmaceutical Greenhouse Gas Emissions Reduction Targets Earn Science Based Targets (SBT) Initiative Certification

13 SEP 2019Nutraceuticals: Otsuka Pharmaceutical Enters into Cooperative Agreement with Niigata Prefecture to Support Prefectural Residents' Health Promotion Project

August

28 AUG 2019Pharmaceuticals: Approval for the Additional Formulation of Samsca^® OD Tablets in Japan

23 AUG 2019Nutraceuticals: UL·OS Men's Skincare BrandRenewal Launch of Three Moisturizing Products

22 AUG 2019Corporate: Otsuka Group Adopts CO₂-free Electricity Annual CO₂ Emissions to Decline by Approximately 9%

19 AUG 2019Corporate: Otsuka Pharmaceutical Participates in Summer Events in Tokushima, Japan Exciting Summer in WAJIKI, Tokushima Awa Odori, Oronamin C Drink PRESENTS Awa Odori Sound Festival

July

22 JUL 2019Nutraceuticals: Otsuka Pharmaceutical Enters into Comprehensive Cooperative Agreement with Nagano Prefecture

June

28 JUN 2019Nutraceuticals: POCARI SWEAT Marketing Wins Top Prize at Japan Marketing Awards

28 JUN 2019Nutraceuticals: Deliciously Illustrated SketchCook
Wins in Three Categories at PR Awards Asia 2019 ― Dietary education app promotes awareness about the importance of meals and nutrition to children―

7 JUN 2019Pharmaceuticals: Otsuka and Taiho Announce that Taiho Will Commercialize Two of Astex Pharmaceuticals' Drug Candidates in North America

7 JUN 2019Pharmaceuticals: Otsuka and its Subsidiary Astex Pharmaceuticals, Inc. Announce Positive Results from a Phase III Clinical Trial of Anticancer Candidate ASTX727

May

22 MAY 2019Pharmaceuticals: Otsuka and Japan Kidney Association
to Collaborative on Autosomal Dominant Polycystic Kidney Disease

April

18 APR 2019Pharmaceuticals: Erdafitinib Receives Regulatory Approval in U.S.

12 APR 2019Nutraceuticals: EQUELLE: Dietary Supplement to Support Women's Health
Expansion of US business through launch of sales via D-to-C channel

8 APR 2019Nutraceuticals: Otsuka Pharmaceutical Establishes Health Beverage Subsidiary in Myanmar

March

28 MAR 2019Nutraceuticals: Otsuka Pharmaceutical to Sponsor 30th Southeast Asian Games 2019 (Philippines)

25 MAR 2019Pharmaceuticals: Otsuka's Subsidiary Avanir Pharmaceuticals Reports Phase 3 Data Evaluating Investigational AVP-786 for the Treatment of Moderate-to-Severe Agitation in Patients with Alzheimer's Dementia

11 MAR 2019Pharmaceuticals: Notice regarding the conclusion of co-development/co-promotion activities in Japan for the anti-epileptic drug "E Keppra"

7 MAR 2019Corporate: Otsuka Pharmaceutical Reappointments and New Appointments of Board Members and Statutory Auditors (PDF:56.8 KB)

5 MAR 2019Pharmaceuticals: Selincro Tablets 10mg Launched in Japan

February

27 FEB 2019Nutraceuticals: Refreshing Men's Facial Lotion for Summer ComfortIntroducing UL·OS Medicated Skin Breezy LotionA single product to moisturize, minimize oily shine, and prevent formation of blemishes

19 FEB 2019Nutraceuticals: Otsuka Pharmaceutical to Serve as an Official Partner for Tokyo Marathon 2019
New "Run," "Support," "Boost," Program Benefits All Participants

15 FEB 2019Pharmaceuticals: Otsuka and Lundbeck report phase III data evaluating brexpiprazole for the treatment of manic episodes associated with bipolar I disorder

14 FEB 2019Pharmaceuticals: Designation Description Change of NY-ESO-1・siTCRTM gene therapy product under "SAKIGAKE Designation System"

13 FEB 2019Pharmaceuticals: Avanir Pharmaceuticals, Inc. Reaches Agreement in Principle with U.S. Department of Justice Regarding NUEDEXTA (dextromethorphan HBr and quinidine sulfate) 20 mg/10 mg capsule

5 FEB 2019Pharmaceuticals: The 1st Japan Open Innovation Prize

4 FEB 2019Nutraceuticals: Introducing SOYJOY Crispy Sakura Special Seasonal Flavor from SOYJOY Brand of Whole Soy Nutrition Bars

January

8 JAN 2019Pharmaceuticals: Selincro (nalmefene) Tablets 10mg Receives Regulatory Approval in Japan

4 JAN 2019Pharmaceuticals: Otsuka and Click Therapeutics Collaborate to Develop and Commercialize Digital Therapeutics for Patients with Major Depressive Disorder

View More